ORIFARM GENERICS HOLDING A/S: Financial statements 2019
CVR: 27347223
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ORIFARM GENERICS HOLDING A/S (CVR 27347223) has filed annual accounts for 2019. In 2019, the company reported a gross profit of EUR 1,684,000 and a net result of EUR 9,696,000 compared with EUR 5,504,000 the year before. That is an increase of 99.1% compared with the year before. Equity in the 2019 report amounted to EUR 40,599,000. The solvency ratio was 58.9%. The company had 204 employees in the financial year.
- Revenue
- EUR 0
- Gross Profit
- EUR 1,684,000
- Profit/Loss
- EUR 9,696,000
- Equity
- EUR 40,599,000
- Total Assets
- EUR 68,909,000
- Employees
- 204
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 0 EUR | 1.7M EUR | 9.7M EUR | 40.6M EUR | 204 |
| 2018 | - | 846K EUR | 5.5M EUR | 35.9M EUR | 203 |
| 2017 | - | 701K EUR | 8.5M EUR | 38.5M EUR | 188 |
| 2016 | - | 1M EUR | 9M EUR | 35M EUR | 165 |
| 2015 | - | 5.7M | 5.2M | 194.3M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of August 26, 2019, Ulrik Kronborg Markussen is registered as adm. dir. of ORIFARM GENERICS HOLDING A/S.
As of August 26, 2019, Karsten Haumann has stepped down as adm. dir. of ORIFARM GENERICS HOLDING A/S.
ORIFARM GENERICS HOLDING A/S has published its annual report for 2018. Gross profit came to DKK 846,000, and the net result was DKK 5,504,000.
About ORIFARM GENERICS HOLDING A/S
ORIFARM GENERICS HOLDING A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named COPYFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Birgitte Bøgh-Sørensen, Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 0 employees (2016). In 2025, the company reported revenue of DKK 459,463,000 and a net result of DKK 273,125,000 compared with DKK 89,363,000 the year before. Equity in the 2025 report amounted to DKK 2,399,752,000.
